Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

Sponsor
Children's Oncology Group (Other)
Overall Status
Completed
CT.gov ID
NCT00003793
Collaborator
National Cancer Institute (NCI) (NIH)
294
96
99
3.1
0

Study Details

Study Description

Brief Summary

RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia.

PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who are at risk of developing leukemia from the chemotherapy used to treat sarcoma.

Condition or Disease Intervention/Treatment Phase
  • Genetic: clonality analysis
  • Genetic: microsatellite instability analysis
  • Genetic: mutation analysis

Detailed Description

OBJECTIVES:
  • Identify genetically susceptible patients to therapy-induced myelodysplastic syndrome or acute myelogenous leukemia (t-MDS/AML) prior to initiation of high-dose chemotherapy for sarcoma.

  • Identify patients who are at increased risk of t-MDS/AML during or after therapy.

OUTLINE: Blood is collected from patients at diagnosis (preferably before chemotherapy or transfusion), at end of therapy, and at 6 months, 1 year, 2 years, and 3 years after therapy.

Blood specimens are examined by clonality analysis (HUMARA), variant cell frequency (glycophorin A assay), GST NAT2/CYP1A1 genotyping, microsatellite instability, and ras mutation detection (single strand conformation polymorphism and sequencing of mutant alleles).

Patients do not receive the results of the genetic testing and the results do not influence the type or duration of treatment.

PROJECTED ACCRUAL: A total of 321 patients will be accrued for this study within 4 years.

Study Design

Study Type:
Observational
Actual Enrollment :
294 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Clinical and Biological Predictors of Therapy-Related Leukemia
Study Start Date :
Dec 1, 1998
Actual Primary Completion Date :
Dec 1, 2005
Actual Study Completion Date :
Mar 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Identification of Genetical suceptibility prior to therapy

Determine the glutathione-s-transferase theta (GSTT1) or glutathione-s-transferase mu (GSTM1) null genotype is more frequent in individuals with t-MDS/AML. Determine the GSTT1 or GSTM1 null genotype is associated with a reduced incidence of relapse of sarcoma. Determine NAT2 or CYP1A1 genotype influences risk of t-MDS/AML. Determine development of a "mutator phenotype" as demonstrated by developing microsatellite instability is an early marker of individuals likely to progress to t-MDS/AML.

Genetic: microsatellite instability analysis

Genetic: mutation analysis

Increased Risk Of T-MDS/AML before/after Therapy

Determine clonal hematopoiesis develops in children receiving high intensity alkylating agent chemotherapy for sarcomas. Determine development of clonal hematopoiesis is associated with increased frequency of t-MDS/AML. Determine measurement of somatic cell mutation frequency, measured by the glycophorin A (GPA) assay prior to and after chemotherapy will predict individuals at increased risk of t-MDS/AML. Identify individuals with ras gene mutations in normal peripheral blood cells after therapy, and whether the identification of such mutations is associated with increased risk of t-MDS/AML blood cells after therapy, and whether the identification of such mutations is associated with increased risk of t-MDS/AML.

Genetic: clonality analysis

Genetic: microsatellite instability analysis

Genetic: mutation analysis

Outcome Measures

Primary Outcome Measures

  1. Event Free Survival []

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Diagnosis of sarcoma including:

  • Rhabdomyosarcoma

  • Ewing's sarcoma

  • Primitive neuroectodermal tumor

  • Fibrosarcoma

  • Malignant peripheral nerve sheath tumor

  • Synovial cell sarcoma

  • Osteosarcoma

  • Other soft tissue sarcoma

  • Must be currently receiving intensive or high-dose chemotherapy for sarcoma

PATIENT CHARACTERISTICS:
Age:
  • Children
Performance status:
  • Not specified
Life expectancy:
  • Not specified
Hematopoietic:
  • Not specified
Hepatic:
  • Not specified
Renal:
  • Not specified
PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • See Disease Characteristics

Endocrine therapy

  • Not specified

Radiotherapy

  • Not specified

Surgery

  • Not specified

Contacts and Locations

Locations

Site City State Country Postal Code
1 Southern California Permanente Medical Group Downey California United States 90242
2 Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach California United States 90806
3 Jonsson Comprehensive Cancer Center at UCLA Los Angeles California United States 90095-1781
4 Children's Hospital Central California Madera California United States 93638
5 UCSF Comprehensive Cancer Center San Francisco California United States 94115
6 Stanford Comprehensive Cancer Center at Stanford University Medical Center Stanford California United States 94305
7 Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center Farmington Connecticut United States 06360-2875
8 Alfred I. duPont Hospital for Children Wilmington Delaware United States 19899
9 Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington District of Columbia United States 20007
10 Children's National Medical Center Washington District of Columbia United States 20010-2970
11 Lee Cancer Care of Lee Memorial Health System Fort Myers Florida United States 33901
12 University of Florida Shands Cancer Center Gainesville Florida United States 32610-0232
13 Nemours Children's Clinic Jacksonville Florida United States 32207-8482
14 Miami Children's Hospital Miami Florida United States 33155
15 Baptist-South Miami Regional Cancer Program Miami Florida United States 33176-2197
16 Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando Florida United States 32803-1273
17 All Children's Hospital St. Petersburg Florida United States 33701
18 St. Joseph's Cancer Institute at St. Joseph's Hospital Tampa Florida United States 33607
19 Kaplan Cancer Center at St. Mary's Medical Center West Palm Beach Florida United States 33407
20 Winship Cancer Institute of Emory University Atlanta Georgia United States 30322
21 Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia United States 31403-3089
22 Children's Memorial Hospital - Chicago Chicago Illinois United States 60614
23 Blank Children's Hospital Des Moines Iowa United States 50309
24 Kosair Children's Hospital Louisville Kentucky United States 40232
25 Children's Hospital of New Orleans New Orleans Louisiana United States 70118
26 CancerCare of Maine at Eastern Maine Medial Center Bangor Maine United States 04401
27 Maine Children's Cancer Program Scarborough Maine United States 04074
28 C.S. Mott Children's Hospital at University of Michigan Ann Arbor Michigan United States 48109-0286
29 Barbara Ann Karmanos Cancer Institute Detroit Michigan United States 48201-1379
30 Hurley Medical Center Flint Michigan United States 48503
31 Spectrum Health Hospital - Butterworth Campus Grand Rapids Michigan United States 49503
32 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods Michigan United States 48236
33 CCOP - Kalamazoo Kalamazoo Michigan United States 49007-3731
34 Children's Hospitals and Clinics of Minneapolis Minneapolis Minnesota United States 55404
35 University of Minnesota Medical Center & Children's Hospital - Fairview Minneapolis Minnesota United States 55455
36 Mayo Clinic Cancer Center Rochester Minnesota United States 55905
37 University of Mississippi Medical Center Jackson Mississippi United States 39216-4505
38 Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri United States 65203
39 Children's Mercy Hospital Kansas City Missouri United States 64108
40 Siteman Cancer Center at Barnes-Jewish Hospital St. Louis Missouri United States 63110
41 Hackensack University Medical Center Cancer Center Hackensack New Jersey United States 07601
42 Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx New York United States 10461
43 Maimonides Cancer Center at Maimonides Medical Center Brooklyn New York United States 11220
44 Roswell Park Cancer Institute Buffalo New York United States 14263-0001
45 NYU Cancer Institute at New York University Medical Center New York New York United States 10016
46 Mount Sinai Medical Center New York New York United States 10029
47 Herbert Irving Comprehensive Cancer Center at Columbia University New York New York United States 10032
48 Stony Brook University Cancer Center Stony Brook New York United States 11794-8174
49 SUNY Upstate Medical University Hospital Syracuse New York United States 13210
50 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina United States 27599-7295
51 Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina United States 28232-2861
52 Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina United States 28233-3549
53 Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina United States 27157-1096
54 CCOP - MeritCare Hospital Fargo North Dakota United States 58122
55 Children's Hospital Medical Center of Akron Akron Ohio United States 44308-1062
56 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229-3039
57 Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States 44195
58 Columbus Children's Hospital Columbus Ohio United States 43205-2696
59 Children's Medical Center - Dayton Dayton Ohio United States 45404-1815
60 Tod Children's Hospital - Forum Health Youngstown Ohio United States 44501
61 Oklahoma University Medical Center Oklahoma City Oklahoma United States 73104
62 Institute of Oncology at Vilnius University Portland Oregon United States 97227
63 Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania United States 17033-0850
64 St. Christopher's Hospital for Children Philadelphia Pennsylvania United States 19134-1095
65 Children's Hospital of Pittsburgh Pittsburgh Pennsylvania United States 15213
66 Greenville Hospital System Cancer Center Greenville South Carolina United States 29605
67 East Tennessee Children's Hospital Knoxville Tennessee United States 37901
68 Vanderbilt-Ingram Cancer Center Nashville Tennessee United States 37232-6838
69 Texas Tech University Health Sciences Center School of Medicine - Amarillo Amarillo Texas United States 79106
70 Medical City Dallas Hospital Dallas Texas United States 75230
71 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas United States 75390
72 Cook Children's Medical Center - Fort Worth Fort Worth Texas United States 76104
73 Covenant Children's Hospital Lubbock Texas United States 79410
74 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78229-3900
75 Methodist Children's Hospital of South Texas San Antonio Texas United States 78229
76 CCOP - Scott and White Hospital Temple Texas United States 76508
77 INOVA Fairfax Hospital Fairfax Virginia United States 22042-3300
78 Children's Hospital of The King's Daughters Norfolk Virginia United States 23507
79 Providence Cancer Center at Sacred Heart Medical Center Spokane Washington United States 99204
80 West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division Charleston West Virginia United States 25302
81 Edwards Comprehensive Cancer Center at Cabell Huntington Hospital Huntington West Virginia United States 25701
82 St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin United States 54307-3508
83 Marshfield Clinic - Marshfield Center Marshfield Wisconsin United States 54449
84 Office of S. David Lang Herston, Brisbane Queensland Australia QLD 4029
85 Royal Children's Hospital Parkville Victoria Australia 3052
86 Princess Margaret Hospital for Children Perth Western Australia Australia 6001
87 Children's & Women's Hospital of British Columbia Vancouver British Columbia Canada V6H 3V4
88 CancerCare Manitoba Winnipeg Manitoba Canada R3E 0V9
89 IWK Health Centre Halifax Nova Scotia Canada B3K 6R8
90 McMaster Children's Hospital at Hamilton Health Sciences Hamilton Ontario Canada L8N 3Z5
91 Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston Ontario Canada K7L 5P9
92 Children's Hospital of Eastern Ontario Ottawa Ontario Canada K1H 8L1
93 Hospital for Sick Children Toronto Ontario Canada M5G 1X8
94 Hopital Sainte Justine Montreal Quebec Canada H3T 1C5
95 Centre Hospitalier Universitaire de Quebec Ste-Foy Quebec Canada G1R 2J6
96 Saskatoon Cancer Centre at the University of Saskatchewan Saskatoon Saskatchewan Canada S7N 4H4

Sponsors and Collaborators

  • Children's Oncology Group
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Stella M. Davies, MBBS, PhD, Children's Hospital Medical Center, Cincinnati

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Children's Oncology Group
ClinicalTrials.gov Identifier:
NCT00003793
Other Study ID Numbers:
  • AB9804
  • COG-AB9804
  • CCG-B9804
  • CDR0000066936
First Posted:
Jan 27, 2003
Last Update Posted:
Aug 5, 2014
Last Verified:
Aug 1, 2014

Study Results

No Results Posted as of Aug 5, 2014